Aroa Biosurgery Limited (ASX:ARX)
0.6450
-0.0150 (-2.27%)
Jun 5, 2026, 3:32 PM AEST
Aroa Biosurgery Balance Sheet
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 21.06 | 7.99 | 11.52 | 9.54 | 6.17 |
Short-Term Investments | 6.08 | 14.16 | 18.7 | 36.39 | 51.24 |
Cash & Short-Term Investments | 27.14 | 22.15 | 30.23 | 45.93 | 57.4 |
Cash Growth | 22.52% | -26.72% | -34.20% | -19.98% | 55.29% |
Accounts Receivable | 39.23 | 32.28 | 26.28 | 22.72 | 15.13 |
Other Receivables | 1.39 | 1.78 | 2.61 | 3.02 | 2.04 |
Receivables | 40.63 | 34.06 | 28.89 | 25.74 | 17.17 |
Inventory | 6.02 | 8.27 | 8.1 | 4.83 | 3.98 |
Prepaid Expenses | 3.5 | 2.41 | 1.82 | 1.44 | 1.33 |
Other Current Assets | - | - | - | 0.19 | - |
Total Current Assets | 77.28 | 66.88 | 69.04 | 78.14 | 79.88 |
Property, Plant & Equipment | 20.71 | 21.51 | 22.22 | 20.64 | 15.36 |
Goodwill | 5.54 | 5.54 | 5.54 | 5.54 | 5.54 |
Other Intangible Assets | 7.89 | 9.11 | 10.11 | 10.75 | 11.73 |
Long-Term Accounts Receivable | 3.18 | 1.3 | - | - | - |
Long-Term Deferred Charges | 5.98 | 4.46 | 4.05 | 1.33 | - |
Other Long-Term Assets | 0.06 | 0.08 | 0.1 | 0.13 | 0.15 |
Total Assets | 120.64 | 108.87 | 111.06 | 116.52 | 112.65 |
Accounts Payable | 5.86 | 2.93 | 1.71 | 1.91 | 1.33 |
Accrued Expenses | 5.78 | 3.61 | 5.74 | 5.44 | 4.69 |
Current Portion of Leases | 1.48 | 1.12 | 1 | 0.56 | 0.59 |
Current Income Taxes Payable | - | - | - | - | 0.05 |
Current Unearned Revenue | 1.29 | - | - | - | - |
Other Current Liabilities | 1.8 | 2.64 | 1.06 | 0.01 | 0.05 |
Total Current Liabilities | 16.21 | 10.3 | 9.51 | 7.91 | 6.71 |
Long-Term Leases | 4.9 | 5.3 | 6.43 | 6.55 | 5.29 |
Other Long-Term Liabilities | 0.2 | 0.19 | 0.17 | 0.17 | 0.16 |
Total Liabilities | 21.31 | 15.79 | 16.12 | 14.63 | 12.16 |
Common Stock | 147.11 | 146.84 | 146.8 | 146.49 | 145.76 |
Retained Earnings | -53.81 | -64.06 | -62.15 | -51.52 | -51.13 |
Comprehensive Income & Other | 6.04 | 10.3 | 10.29 | 6.92 | 5.86 |
Shareholders' Equity | 99.34 | 93.09 | 94.94 | 101.89 | 100.49 |
Total Liabilities & Equity | 120.64 | 108.87 | 111.06 | 116.52 | 112.65 |
Total Debt | 6.38 | 6.42 | 7.44 | 7.11 | 5.88 |
Net Cash (Debt) | 20.76 | 15.73 | 22.79 | 38.83 | 51.53 |
Net Cash Growth | 31.95% | -30.96% | -41.30% | -24.65% | 148.56% |
Net Cash Per Share | 0.06 | 0.05 | 0.07 | 0.11 | 0.15 |
Filing Date Shares Outstanding | 345.48 | 344.9 | 344.21 | 343.11 | 342.46 |
Total Common Shares Outstanding | 345.48 | 344.9 | 344.21 | 343.11 | 342.46 |
Working Capital | 61.07 | 56.58 | 59.52 | 70.22 | 73.17 |
Book Value Per Share | 0.29 | 0.27 | 0.28 | 0.30 | 0.29 |
Tangible Book Value | 85.91 | 78.43 | 79.29 | 85.6 | 83.22 |
Tangible Book Value Per Share | 0.25 | 0.23 | 0.23 | 0.25 | 0.24 |
Machinery | 15.21 | 14.55 | 12.6 | 11.93 | 10.48 |
Construction In Progress | 8.34 | 8.41 | 8.32 | 5.73 | 4.17 |
Leasehold Improvements | 5.6 | 5.08 | 4.88 | 4.62 | 1.63 |